In addition, after interaction with myeloma cells, MM-MSCs secrete less osteoprotegerin (OPG), a soluble decoy receptor for RANKL, thus contributing to the increased RANKL/OPG ratio that promotes OC formation and resorption [176]. Here, TNFRSF11B is linked to Miyoshi myopathy.